Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants

被引:127
作者
Avet-Loiseau, H
Garand, R
Lodé, L
Harousseau, JL
Bataille, R
机构
[1] Univ Hosp Nantes, Hematol Lab, Nantes, France
[2] Univ Hosp Nantes, Dept Clin Hematol, Nantes, France
关键词
D O I
10.1182/blood-2002-08-2436
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In an attempt to address the issue of cytogenetic features of multiple myeloma (MM) variants, we have analyzed a series of 8 IgM, 9 IgD, 2 IgE, and 14 nonsecretory (NS) MM cases using fluorescence in situ hybridization. A very high incidence (83%) of t(11;14)(q13;q32) was detected in the IgM (7 of 8), IgE (2 of 2), and NS (11 of 14) MM cases, but not in the IgD cases (2 of 9). Of note, no t(4;l 4) was observed in this cohort of patients. This increased incidence of t(11;14) was associated with 2 dominant features in these variants, namely, a "lymphoplasmacytic" presentation mainly in IgM MM and a lower secreting capacity in the others, 2 features previously associated with t(11;14). Of major interest, t(11;14) was never observed in Waldenstrom macroglobullnemia or in IgG/IgA "lymphoplasmacytic" lymphomas. Thus, for unknown masons, t(11;14) is the hallmark of IgM, IgE, and NS MM, (but not IgD MM), with a 5-fold increase of its incidence compared to that of IgG and IgA MM.
引用
收藏
页码:1570 / 1571
页数:2
相关论文
共 13 条
[1]   Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation [J].
Avet-Loiseau, H ;
Facon, T ;
Grosbois, B ;
Magrangeas, F ;
Rapp, MJ ;
Harousseau, JL ;
Minvielle, S ;
Bataille, R .
BLOOD, 2002, 99 (06) :2185-2191
[2]   HISTOLOGIC CLASSIFICATION AND STAGING OF MULTIPLE-MYELOMA - A RETROSPECTIVE AND PROSPECTIVE-STUDY OF 674 CASES [J].
BARTL, R ;
FRISCH, B ;
FATEHMOGHADAM, A ;
KETTNER, G ;
JAEGER, K ;
SOMMERFELD, W .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (03) :342-355
[3]   NON-SECRETORY MULTIPLE-MYELOMA [J].
DREICER, R ;
ALEXANIAN, R .
AMERICAN JOURNAL OF HEMATOLOGY, 1982, 13 (04) :313-318
[4]   Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients [J].
Fonseca, R ;
Blood, EA ;
Oken, MM ;
Kyle, RA ;
Dewald, GW ;
Bailey, RJ ;
Van Wier, SA ;
Henderson, KJ ;
Hoyer, JD ;
Harrington, D ;
Kay, NE ;
Van Ness, B ;
Greipp, PR .
BLOOD, 2002, 99 (10) :3735-3741
[5]   Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell [J].
Gabrea, A ;
Bergsagel, PL ;
Chesi, M ;
Shou, YP ;
Kuehl, WM .
MOLECULAR CELL, 1999, 3 (01) :119-123
[6]   IgG-secreting lymphoplasmacytoid leukaemia:: a B-cell disorder with extensively mutated VH genes undergoing Ig isotype-switching frequently associated with trisomy 12 [J].
Garand, R ;
Sahota, SS ;
Avet-Loiseau, H ;
Talmant, P ;
Robillard, N ;
Moreau, A ;
Gaillard, F ;
Stevenson, FK ;
Bataille, R .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) :71-80
[7]   Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis [J].
Hayman, SR ;
Bailey, RJ ;
Jalal, SM ;
Ahmann, GJ ;
Dispenzieri, A ;
Gertz, MA ;
Greipp, PR ;
Kyle, RA ;
Lacy, MQ ;
Rajkumar, SV ;
Witzig, TE ;
Lust, JA ;
Fonseca, R .
BLOOD, 2001, 98 (07) :2266-2268
[8]  
Juge-Morineau N, 1997, CLIN CANCER RES, V3, P2501
[9]  
MacLennan I C, 1992, Curr Top Microbiol Immunol, V182, P209
[10]   Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy [J].
Moreau, P ;
Facon, T ;
Leleu, X ;
Morineau, N ;
Huyghe, P ;
Harousseau, JL ;
Bataille, R ;
Avet-Loiseau, H .
BLOOD, 2002, 100 (05) :1579-1583